These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8790143)

  • 1. The use of rhG-CSF in chronic autoimmune neutropenia: reversal of autoimmune phenomena, a case history.
    Kuijpers TW; de Haas M; de Groot CJ; von dem Borne AE; Weening RS
    Br J Haematol; 1996 Sep; 94(3):464-9. PubMed ID: 8790143
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The plasma concentration of soluble Fc-gamma RIII is related to production of neutrophils.
    Huizinga TW; de Haas M; van Oers MH; Kleijer M; Vilé H; van der Wouw PA; Moulijn A; van Weezel H; Roos D; von dem Borne AE
    Br J Haematol; 1994 Jul; 87(3):459-63. PubMed ID: 7527644
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutropenia due to antibodies against Type III Fc receptors on neutrophil granulocytes: 3 children with different clinical courses].
    Geukers VG; Veenhoven RH; Schouten-van Meeteren AY; Bruin MC; de Haas M
    Ned Tijdschr Geneeskd; 1998 Feb; 142(7):362-4. PubMed ID: 9562743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neutrophils express the high affinity receptor for IgG (Fc gamma RI, CD64) after in vivo application of recombinant human granulocyte colony-stimulating factor.
    Repp R; Valerius T; Sendler A; Gramatzki M; Iro H; Kalden JR; Platzer E
    Blood; 1991 Aug; 78(4):885-9. PubMed ID: 1714327
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Altered function and surface marker expression of neutrophils induced by rhG-CSF treatment in severe congenital neutropenia.
    Elsner J; Roesler J; Emmendörffer A; Zeidler C; Lohmann-Matthes ML; Welte K
    Eur J Haematol; 1992 Jan; 48(1):10-9. PubMed ID: 1370419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reversal of autoimmune phenomena in autoimmune neutropenia after treatment with rhG-CSF: two additional cases.
    Carulli G; Sbrana S; Azzarà A; Minnucci S; Angiolini C; Ambrogi F
    Br J Haematol; 1997 Mar; 96(4):877-8. PubMed ID: 9074439
    [No Abstract]   [Full Text] [Related]  

  • 7. Human granulocyte colony-stimulating factor may improve outcome attributable to neonatal sepsis complicated by neutropenia.
    Kocherlakota P; La Gamma EF
    Pediatrics; 1997 Jul; 100(1):E6. PubMed ID: 9200380
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human recombinant granulocyte colony-stimulating factor for the treatment of autoimmune neutropenia.
    Takahashi K; Taniguchi S; Akashi K; Fujimoto K; Sibuya T; Ishibashi H; Harada M; Niho Y
    Acta Haematol; 1991; 86(2):95-8. PubMed ID: 1719726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human granulocyte colony-stimulating factor therapy for cyclic neutropenia associated with common variable immunodeficiency.
    Tsuda M; Urakami T; Watanabe S; Shimizu H; Inana I; Kikkawa Y; Kitagawa T
    Acta Paediatr Jpn; 1993 Apr; 35(2):124-6. PubMed ID: 7684881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Treatment of chemotherapy-induced neutropenia pegylated recombinant human granulocyte colony-stimulating factor: a multi-center randomized controlled phase II clinical study].
    Shi YK; He XH; Yang S; Wang HQ; Jiang ZF; Zhu YZ; Ke XY; Zhang Y; Liu YP; Zhang WJ; Wang Z; Shi QZ; Xie XD; Zhang HL; Wang JJ; Luo DY; Zheng QS; Sun RY
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(48):3414-9. PubMed ID: 17313855
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Phase I clinical trail of intravenous pegylated recombinant human granulocyte colony-stimulating factor].
    Shi YK; Liu P; Yang S; Han XH; He XH; Ai B; Qin Y; Li B; Huang DZ; Zhang CG; Sun Y
    Ai Zheng; 2006 Apr; 25(4):495-500. PubMed ID: 16613688
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical effect of recombinant human granulocyte colony-stimulating factor (rhG-CSF) on various types of neutropenia including cyclic neutropenia.
    Hirashima K; Yoshida Y; Asano S; Takaku F; Omine M; Furusawa S; Abe T; Abe T; Dohy H; Tajiri M
    Biotherapy; 1991; 3(4):297-307. PubMed ID: 1723891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose recombinant human granulocyte colony-stimulating factor therapy in children with symptomatic chronic idiopathic neutropenia.
    Bernini JC; Wooley R; Buchanan GR
    J Pediatr; 1996 Oct; 129(4):551-8. PubMed ID: 8859262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Chronic neutropenia - experience from the Department of Immunology, Children's Memorial Health Institute].
    Klaudel-Dreszler M; Pietrucha B; Skopczynska H; Pac M; Kurenko-Deptuch M; Heropolitanska-Pliszka E; Wolska-Kusnierz B; Maslanka K; Bernatowska E
    Med Wieku Rozwoj; 2007; 11(2 Pt 1):145-52. PubMed ID: 17625284
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased levels of myeloid progenitor cells associated with long-term administration of recombinant human granulocyte colony-stimulating factor in patients with autoimmune neutropenia.
    Taniguchi S; Shibuya T; Harada M; Niho Y
    Br J Haematol; 1993 Mar; 83(3):384-7. PubMed ID: 7683484
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical evaluation of effects of KRN8601 (rhG-CSF) on neutropenia].
    Nakahata T; Akabane T; Miura A; Tada K; Uzuka Y; Hayashi T; Shibata A; Shiko S; Okuni M; Urabe A
    Rinsho Ketsueki; 1992 Feb; 33(2):123-32. PubMed ID: 1378911
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The effects and pharmacokinetics of rhG-CSF on the treatment of neutropenia in patients with renal failure].
    Shishido K; Niikura K; Akizawa T; Koshikawa S
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):973-81. PubMed ID: 1722829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Changes in neutrophil counts and functions after the administration of recombinant human granulocyte colony-stimulating factor in a patient with chronic idiopathic neutropenia].
    Sai M; Kawanishi Y; Kuriyama K; Kuratsuji T; Toyama K
    Rinsho Ketsueki; 1990 Apr; 31(4):484-6. PubMed ID: 1696326
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical experience with the use of rhG-CSF in secondary autoimmune neutropenia.
    Smith MA; Smith JG
    Clin Lab Haematol; 2002 Apr; 24(2):93-7. PubMed ID: 11985554
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of rhG-CSF on infection complications and impaired function of neutrophils secondary to chemotherapy for non-Hodgkin's lymphoma. Hokkaido Study Group of Malignant Lymphoma, and rhG-CSF, Japan.
    Kuni-Eda Y; Okabe M; Kurosawa M; Maekawa I; Higuchi M; Kawamura M; Morioka M; Suzuki S; Ohmura T; Fujimoto N
    Leuk Lymphoma; 1995 Feb; 16(5-6):471-6. PubMed ID: 7540462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.